News

Long-acting Basal Insulin Controls A1C as Well as Glargine

Publish date: September 16, 2015
Author and Disclosure Information

 

AT EASD 2015

References

Eli Lilly & Co. funded the study. Dr. Garg has received research funding from the company.

Pages

Recommended Reading

Be Sure to Look for Secondary Diabetes
Clinician Reviews
Weighted CMDS Score Predicts 15-year Diabetes Risk
Clinician Reviews
For Diabetic Patients, LRYGB Safety Comparable to Other Common Procedures
Clinician Reviews
Skipping Breakfast Incites Hyperglycemic Response in Type 2 Diabetes Patients
Clinician Reviews
Beware of Skin Complications of Newer Antidiabetic Agents
Clinician Reviews
In Diabetic Foot Ulcers, Use 50% Rule to Gauge Need for Advanced Therapies
Clinician Reviews
VIDEO: Newer Type 2 Diabetes Drugs Pose No Significant Heart Failure Risk
Clinician Reviews
Diabetes Prevalence Rising, Especially in Black, Asian, and Hispanic Populations
Clinician Reviews
High-calorie American Diet Causes Insulin Resistance Within Days
Clinician Reviews
EASD: High A1C Linked to Elevated Dementia Risk in Patients With T2DM
Clinician Reviews